PMID- 28718889 OWN - NLM STAT- MEDLINE DCOM- 20180723 LR - 20220408 IS - 1525-1594 (Electronic) IS - 0160-564X (Linking) VI - 41 IP - 12 DP - 2017 Dec TI - Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients Undergoing Aortic Surgery. PG - 1113-1120 LID - 10.1111/aor.12951 [doi] AB - Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an option for mechanical support for patients with postcardiotomy cardiogenic shock (PCS). However, the use of VA-ECMO in patients suffering from aortic disease with PCS has not been greatly reported. This is a retrospective review of adult patients undergoing aortic surgery who received VA-ECMO support to treat refractory PCS from August 2009 to May 2016. A total of 36 patients who underwent aortic surgery with VA-ECMO support for refractory PCS were included. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible correlation with in-hospital mortality. After a mean duration of 3.6 +/- 2.9 days, 24 patients (67%) were weaned off VA-ECMO, and 18 patients (50%) were discharged from the hospital. The overall in-hospital mortality was 50%. The main cause of death was multiple organ dysfunction. The survivors had a lower level of preoperative creatine kinase-MB (CK-MB), a higher rate of antegrade cannulation, and a lower lactate level at 12 h, respectively. Relevant factors for in-hospital mortality were retrograde-flow cannulation (odds ratio [OR], 2.49), peak lactate levels greater than 20 mmol/L (OR, 5.0), and preoperative CK-MB greater than 100 IU/L (OR, 6.40). Antegrade cannulation may provide better perfusion and should be emphasized to improve outcomes. Additionally, levels of peak serum lactate and preoperative CK-MB may be relevant factors for in-hospital mortality in aortic patients with PCS. CI - (c) 2017 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc. FAU - Zhong, Zhaopeng AU - Zhong Z AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. AD - Beijing Institute of Heart Lung Blood Vessel Disease, Beijing, China. FAU - Jiang, Chunjing AU - Jiang C AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. FAU - Yang, Feng AU - Yang F AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. FAU - Hao, Xing AU - Hao X AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. FAU - Xing, Jialin AU - Xing J AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. FAU - Wang, Hong AU - Wang H AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. FAU - Hou, Xiaotong AU - Hou X AUID- ORCID: 0000-0002-7047-0492 AD - Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. AD - Beijing Institute of Heart Lung Blood Vessel Disease, Beijing, China. LA - eng PT - Journal Article DEP - 20170718 PL - United States TA - Artif Organs JT - Artificial organs JID - 7802778 SB - IM MH - Adult MH - Aged MH - Aortic Diseases/blood/*complications/mortality/*surgery MH - *Extracorporeal Membrane Oxygenation/methods MH - Female MH - Hospital Mortality MH - Humans MH - Male MH - Middle Aged MH - Perioperative Period MH - Retrospective Studies MH - Shock, Cardiogenic/blood/*complications/mortality/*therapy MH - Treatment Outcome OTO - NOTNLM OT - -Aortic surgery OT - -Postcardiotomy cardiogenic shock OT - Extracorporeal membrane oxygenation EDAT- 2017/07/19 06:00 MHDA- 2018/07/24 06:00 CRDT- 2017/07/19 06:00 PHST- 2016/12/19 00:00 [received] PHST- 2017/02/18 00:00 [revised] PHST- 2017/03/14 00:00 [accepted] PHST- 2017/07/19 06:00 [pubmed] PHST- 2018/07/24 06:00 [medline] PHST- 2017/07/19 06:00 [entrez] AID - 10.1111/aor.12951 [doi] PST - ppublish SO - Artif Organs. 2017 Dec;41(12):1113-1120. doi: 10.1111/aor.12951. Epub 2017 Jul 18.